In an attempt to investigate if TIMP-2 not only serves as a biomarker for AKI, but may itself also be involved in the protection from AKI, we pretreated WT and TIMP-2–deficient mice with HMGB1 and subsequently induced AKI using IRI in these animals. Here, HMGB1 is linked to acute kidney injury.